Virtual Medicinal Product (VMP) - Androstanolone 2.5% gel
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Androstanolone 2.5% gel | Start Date 20-04-2007 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- Schedule 4 (CD Anab)
- Route
- Cutaneous
- Form
- Cutaneous gel
- Ontology Form/Route
- gel.cutaneous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- A14AA01
- BNF Codes
-
- BNF code 06040300
| Code | Start Date | End Date |
|---|---|---|
| 11474411000001104 | 20-04-2007 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Androstanolone | Based on Ingredient Substance | 25 mg | 1 gram |
Name
Androstanolone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
25
Strength and UOM (Dmr)
1
Parent Products
-
VTMAndrostanolone
-
VMP(Current) Androstanolone 2.5% gel
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 gram | ||
| 80 gram |